Dr Reddys Laboratories (RDY) Enterprise Value Growth (3y) (2012 - 2026)
Dr Reddys Laboratories (RDY) Enterprise Value Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.27% |
| Mar 31, 2025 | 32.61% |
| Mar 31, 2024 | 26.60% |
| Mar 31, 2023 | -21.53% |
| Mar 31, 2022 | -150.99% |
| Mar 31, 2021 | -36.74% |
| Dec 31, 2020 | 99.68% |
| Sep 30, 2020 | 25.99% |
| Mar 31, 2020 | -34.78% |
| Dec 31, 2019 | 99.43% |
| Sep 30, 2019 | 25.99% |
| Dec 31, 2018 | 81.55% |
| Jun 30, 2018 | 76.46% |
| Mar 31, 2018 | 94.12% |
| Dec 31, 2017 | 8.97% |
| Sep 30, 2017 | -8,223.97% |
| Dec 31, 2016 | -8,283.82% |
| Sep 30, 2016 | -9,500.35% |
| Jun 16, 2016 | -76.68% |
| Dec 31, 2015 | -26.09% |